
Clinical features and COMP gene mutation in a family with a pseudoachondroplasia child
LU Chun-Ting, GUO Li, ZAHNG Zhan-Hui, LIN Wei-Xia, SONG Yuan-Zong, FENG Lie
Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (11) : 937-941.
Clinical features and COMP gene mutation in a family with a pseudoachondroplasia child
Pseudoachondroplasia / COMP gene / Mutation / Molecular cloning / Child
[1] Briggs MD, Chapman KL. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations [J] . Hum Mutat, 2002, 19(5): 465-478.
[2] Andrea SF, Sheila U. Nosology and classification of genetic skeletal disorders: 2006 revision [J] . Am J Med Genet A, 2007, 143A(1): 1-18.
[3] Posey KL, Hecht JL. The role of cartilage oligomeric matrix protein(COMP) in skeletal disease [J] . Curr Drug Targets, 2008, 9(10): 869-877.
[4] Mckeand I, Rotta J, Hecha JL. Natural history study of pseudoachondroplasia [J] . Am J Med Genet, 1996, 63(2): 406-410.
[5] Rimoin DL, Rasmussen IM, Briggs MD, Biggs MD, Roughley PJ, Gruber HE, et al. A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix [J] . Hum Genet, 1994, 93(3): 236-242.
[6] Wynne-Davies R, Hall CM, Young ID. Pseudoachondroplasia: clinical diagnosis at different ages and comparison of autosomal dominant and recessive types. A review of 32 patients(26 kindreds) [J] . J Med Genet, 1986, 23(5): 425-434.
[7] Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene [J] . Nat Genet, 1995, 10(3):330-336.
[8] Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FFB, Harrison WR, et al. Mutations in exon 17B of cartilage oligomeric matrix protein(COMP) cause pseudoachondroplasia [J] . Nat Genet, 1995, 10(3): 325-329.
[9] Briggs MD, Rasmussen IM, Weber JL, Yuen J, Reinker K, Garber AP, et al. Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19 [J] . Genomics, 1993, 18(3): 656-660.
[10] Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, et al. Characterization of human and mouse cartilage oligomeric matrix protein [J] . Genomics, 1994, 24(3): 435-439.
[11] Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins [J] . J Biol Chem, 1992, 267(31): 22346-22350.
[12] Halasz K, Kassner A, Morgelin M, Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis [J] . J Biol Chem, 2007, 282(43): 31166-31173.
[13] Xu K, Zhang Y, Ilalov K, Carlson CS, Feng JQ, Di Cesare PE, et al. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation [J] . J Biol Chem, 2007, 282(15): 11347-11355.
[14] Gagarina V, Carlberg AL, Pereira-Mouries L, Hall DJ. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins [J] . J Biol Chem, 2008, 283(1): 648-659.
[15] Duke J, Montufar-Solis D, Underwood ZL, Hecht JT. Apoptosis staining in cultured pseudoachondroplasia chondrocytes [J] . Apoptosis, 2003, 8(2): 191-197.
[16] Chen TL, Stevens JW, Cole WQ, Hecht JT, Vertel BM. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH [J]. Matrix Biol, 2004, 23(7): 433-444.
[17] Xie XM, Liao LH, Gao JZ, Luo XP. A novel COMP mutation in a Chinese patient with pseudoachondroplasia [J] . Gene, 2013, 521(1): 102-106.
[18] Wang CH, Lin WD, Tsai A, Tsai FJ. Novel human pathological mutations. Gene symbol: COMP Disease: pseudoachondroplasia [J] . Hum Genet, 2009, 125(3): 350.
[19] Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NST, et al. The Human Gene Mutation Database: 2008 update [J] . Genome Med, 2009, 1(1): 131-136.
[20] Kennedy J, Jackson G, Ramsden S, Taylor J, Newman W, Wright MJ, et al. COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia [J] . Eur J Hum Genet, 2005, 13(5): 547-555.
[21] Deere M, Sanford T, Ferguson HL, Daniels K, Hecht JT. Identification of twelve mutations in cartilage oligomeric matrix protein(COMP) in patients with pseudoachondroplasia [J] . Am J Med Genet, 1998, 80(5): 510-513.
[22] Tufan AC, Satitoglu-Tufan NL, Jackson GC, Semerci CN, Solak S, Yagci B. Serum or plasma cartilage oligomeric matrix protein concentration as a diagnostic marker in pseudoachondroplasia: differential diagnosis of a family [J] . Eur J Hum Gent, 2007, 15(10): 1023-1028.
[23] 顾海滨,唐文伟. 假性软骨发育不全的临床影像学分析 [J] . 南京医科大学学报(自然科学版), 2010, 30(9): 1372-1374.
[24] 李惠民, 王明奎, 董立新, 曹桂民. 假性软骨发育不全的临床及X线诊断 (附6例报告及文献复习) [J] .中华骨科杂志, 1995, 15(2):114-115.
[25] 麻宏伟, 潘诗农, 王阳, 宓真, 姜梅, 武盈玉, 等. 假性软骨发育不全一家系两例 [J] . 中华医学遗传学杂志, 1999,16(4): 223.
[26] 许瑞江, 吴战坡, 卢强, 郝荣国, 曾平. 假性软骨发育不全的诊治 [J] . 临床小儿外科杂志, 2003, 2(6): 419-421.
[27] 张续德, 孟岩, 彭园园, 施惠平, 赵时敏, 黄尚志. 假性软骨发育不全一家系COMP基因突变分析 [J] . 中国实用儿科杂志, 2010, 25(4): 289-291.
[28] Jackson GC, Mittaz-Crettol L, Taylor JA, Mortier GR, Spranger J, Zabel B, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution [J] . Hum Mutat, 2012, 33(1): 144-157.
[29] Mabuchi A, Manabe N, Haga N, Kitoh H, Lkeda T, Kawaji H, et al. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia [J] . Hum Genet, 2003, 112(1): 84-90.
[30] 刘宁, 史惠蓉, 吴庆华, 江淼, 孔祥东. 软骨发育不全家系基因突变分析及孕早期产前诊断 [J] . 中国优生与遗传杂志, 2013, 21(3): 12-13.
[31] 郭奕斌, 王晶晶, 杜传书. 遗传性侏儒及其鉴别诊断 [J] . 中国优生优育杂志, 2007, 15(11): 117.
[32] 赵宏, 赵润博. 小儿软骨发育不全的X线分析 [J] . 中国医学影像技术, 2007, 23(10): 1581-1582.
[33] Ballhausen D, Bonafe L, Terhal P, Unger SL, Bellus G, Classen M, et al. Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W [J] . J Med Genet, 2003, 40(1): 65-71.
[34] Hou J, Putkey JA, Hecht JT. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding [J] . Cell Calcium, 2000, 27(6): 309-314.
[35] Kvansakul M, Adams JC, Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats [J]. Embo J, 2004, 23(6): 1223-1233.
[36] Kleerekoper Q, Hecht JT, Putkey JA. Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain [J] . J Biol Chem, 2002, 277(12): 10581-10589.
[37] Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, et al. Structure of the calcium-rich signature domain of human thrombospondin-2 [J] . Nat Struct Mol Biol, 2005, 12(10): 910-914.
[38] Dudek RW. Genetics Metabolism [M] . // Dudek RW. Genetics. 1th ed. Baltimore, United States: Lippincott Williams & Wilkins, 2009: 224.
[39] Northrup H, Wheless JW, Bertin TK, Lewis RA. Variability of expression in tuberous sclerosis [J] . J Med Genet, 1993, 30(1): 41-43.
[40] Moore AT, Fitzke F, Arden GB, Inglehearn CF, Keen TJ, Bhattacharya SS, et al. Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance:a clinical, electrophysiological, psychophysical, and molecular genetic study [J] . Br J Ophthalmol, 1993, 77(8): 473-479.
[41] Barber JCK. Directly transmitted unbalanced chromosome abnormalities and euchromatic variants [J] . J Med Genet, 2005, 42(8): 609-629.
[42] Sampson JR, Scahill SJ, Stephenson JB, Mann L, Connor JM. Genetic aspects of tuberous sclerosis in the west of Scotland [J] . J Med Genet, 1989, 26(1): 28-31.
[43] Spranger M, Schapera J. Anomalous inheritance in a kindred with split hand, split foot malformation [J] . Eur J Pediatr, 1988, 147(2): 202-205.
[44] Morrison AW, Bundey SE. The inheritance of ostosclerosis[J] . J Laryngol Otol, 1970, 84(9): 921-932.
[45] Causse JR, Causse JB. Otospongiosis as a genetic disease: early detection, medical management, and prevention [J] . Am J Otol, 1984, 5(3): 211-223.
[46] Kanazawa H, Tanaka H, Inoue M, Ymanaka Y, Namba N, Seino Y. Efficacy of growth hormone therapy for patients with skeletal dysplasis [J]. J Bone Miner Metab, 2003, 21(5): 307-310.